Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders

Details for Australian Patent Application No. 2005205067 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Ikonomidou, Hrissanthi; Weske, Michael; Turski, Lechoslaw A.; Ziegler, Dieter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005205067

PCT Pub. Number WO2005/067937

Priority 04100067.0 12.01.04 EP; 60/535,538 12.01.04 US

Filing date 10 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 22 October 2009

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/067937 Priority application(s): WO2005/067937

22 October 2009 Application Accepted

  Published as AU-B-2005205067

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205072-Pharmaceutical compositions comprising midazolam in a high concentration

2005205066-The use of quaternary pyridinium salts as vasoprotective agents